Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
Minimally invasive glaucoma surgery (MIGS) devices are used in glaucoma surgery that avoids conjunctival dissection and includes an internal incision for the treatment of patients suffering from glaucoma. The appearance of MIGS devices has transformed the patient's care with mild-to-moderate glaucoma conditions.
MARKET DYNAMICS
Growing burden of geriatric population and rise in demand for surgeries combining glaucoma and cataract is likely to boosts the market growth. However, unfavorable reimbursement for minimally invasive glaucoma surgery devices is anticipated to hamper the market growth.
MARKET SCOPE
The "Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of minimally invasive glaucoma surgery (MIGS) devices market with detailed market segmentation by surgery, target, product and end user. The minimally invasive glaucoma surgery (MIGS) devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in minimally invasive glaucoma surgery (MIGS) devices market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The minimally invasive glaucoma surgery (MIGS) devices market is segmented on the basis of surgery, target, product and end user. Based on surgery, the market is segmented as glaucoma in conjunction with cataract and stand-alone glaucoma. On the bases of target, the market is segmented as trabecular meshwork, suprachoroidal space, and others. By product is further segmented as MIGS stents, MIGS shunts and other. Based on end user, the market is segmented as Eye hospitals, ophthalmology clinics, and outpatient surgical centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the minimally invasive glaucoma surgery (MIGS) devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The minimally invasive glaucoma surgery (MIGS) devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting minimally invasive glaucoma surgery (MIGS) devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the minimally invasive glaucoma surgery (MIGS) devices market in these regions.
By Surgery
By Target
By Product
By End User
MARKET PLAYERS
The report covers key developments in the minimally invasive glaucoma surgery (MIGS) devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as type launches, type approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from minimally invasive glaucoma surgery (MIGS) devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for minimally invasive glaucoma surgery (MIGS) devices in the global market. Below mentioned is the list of few companies engaged in the minimally invasive glaucoma surgery (MIGS) devices market.
The report also includes the profiles of key players in minimally invasive glaucoma surgery (MIGS) devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Minimally invasive glaucoma surgery (MIGS) devices are used in glaucoma surgery that avoids conjunctival dissection and includes an internal incision for the treatment of patients suffering from glaucoma. The appearance of MIGS devices has transformed the patient's care with mild-to-moderate glaucoma conditions.
MARKET DYNAMICS
Growing burden of geriatric population and rise in demand for surgeries combining glaucoma and cataract is likely to boosts the market growth. However, unfavorable reimbursement for minimally invasive glaucoma surgery devices is anticipated to hamper the market growth.
MARKET SCOPE
The "Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of minimally invasive glaucoma surgery (MIGS) devices market with detailed market segmentation by surgery, target, product and end user. The minimally invasive glaucoma surgery (MIGS) devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in minimally invasive glaucoma surgery (MIGS) devices market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The minimally invasive glaucoma surgery (MIGS) devices market is segmented on the basis of surgery, target, product and end user. Based on surgery, the market is segmented as glaucoma in conjunction with cataract and stand-alone glaucoma. On the bases of target, the market is segmented as trabecular meshwork, suprachoroidal space, and others. By product is further segmented as MIGS stents, MIGS shunts and other. Based on end user, the market is segmented as Eye hospitals, ophthalmology clinics, and outpatient surgical centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the minimally invasive glaucoma surgery (MIGS) devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The minimally invasive glaucoma surgery (MIGS) devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting minimally invasive glaucoma surgery (MIGS) devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the minimally invasive glaucoma surgery (MIGS) devices market in these regions.
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report Analysis
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- NOVARTIS INTERNATIONAL AG
- ALLERGAN PLC
- ELLEX MEDICAL LASERS LTD
- GLAUKOS CORPORATION
- ISTAR MEDICAL SA
- IVANTIS INC
- LUMENIS LTD
- SANTEN PHARMACEUTICAL CO LTD
- SOLX INC
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Surgery
- Glaucoma in Conjunction with Cataract
- Stand-Alone Glaucoma
By Target
- Trabecular Meshwork
- Suprachoroidal Space
- Others
By Product
- MIGS Stents
- MIGS Shunts
- Other
By End User
- Eye Hospitals
- Ophthalmology Clinics
- Outpatient Surgical Centers
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the minimally invasive glaucoma surgery (MIGS) devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as type launches, type approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from minimally invasive glaucoma surgery (MIGS) devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for minimally invasive glaucoma surgery (MIGS) devices in the global market. Below mentioned is the list of few companies engaged in the minimally invasive glaucoma surgery (MIGS) devices market.
The report also includes the profiles of key players in minimally invasive glaucoma surgery (MIGS) devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- NOVARTIS INTERNATIONAL AG
- ALLERGAN PLC.
- ELLEX MEDICAL LASERS LTD.
- GLAUKOS CORPORATION
- ISTAR MEDICAL SA
- IVANTIS INC.
- LUMENIS LTD.
- SANTEN PHARMACEUTICAL CO LTD
- SOLX, INC.
- TOPCON CORPORATION
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Surgery
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. NOVARTIS INTERNATIONAL AG
2. ALLERGAN PLC.
3. ELLEX MEDICAL LASERS LTD.
4. GLAUKOS CORPORATION
5. ISTAR MEDICAL SA
6. IVANTIS INC.
7. LUMENIS LTD.
8. SANTEN PHARMACEUTICAL CO LTD
9. SOLX, INC.
10. TOPCON CORPORATION
1. NOVARTIS INTERNATIONAL AG
2. ALLERGAN PLC.
3. ELLEX MEDICAL LASERS LTD.
4. GLAUKOS CORPORATION
5. ISTAR MEDICAL SA
6. IVANTIS INC.
7. LUMENIS LTD.
8. SANTEN PHARMACEUTICAL CO LTD
9. SOLX, INC.
10. TOPCON CORPORATION
Get Free Sample For